Network for understanding Bipolar Disorder in Norway
Official title: Bipolar Research And Innovation Network - BRAIN
Run by Norwegian University of Science and Technology · NCT00201526 · Data updated 2026-11-12
This study looks at different types of people with Bipolar Disorder in Norway to see how they are doing over time and what factors might affect their health.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Norwegian University of Science and Technology Academic / other |
| Locations | 1 site (Trondheim) |
| Status | Recruiting |
| Started | January 2003 |
| Main results expected | January 2030 |
| Study ends | January 2030 |
| Registry record updated | December 12, 2025 |
| Trial ID | NCT00201526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are all patients diagnosed with Bipolar Disorder who are admitted to psychiatric care and can provide written consent.
✕Probably not a fit
Patients who lack the capacity to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to describe the diverse range of patients with Bipolar Disorder admitted to both outpatient and inpatient psychiatric departments across Norway. It includes all bipolar patients, regardless of the presence of co-morbid disorders, and utilizes a comprehensive approach involving clinical evaluations, imaging studies (CT or MRI), EEGs, and blood sample collection for genetic mapping. The study leverages Norway's homogeneous society and public health system to track patient outcomes over several years.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Bipolar Disorder and improve treatment strategies for patients.
How similar studies have gone: Other studies focusing on the characterization of Bipolar Disorder have shown success in understanding the condition, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All admitted patients giving written consent to participate in the study Exclusion Criteria: * Patients without competence for consent.
Where it's running
-
Medical Faculty, Norwegian University of Science And Technology
Trondheim, Norway Recruiting
Study contacts
- Principal investigator: Gunnar Morken, PhD MD — Norwegian University of Science and Technology
- Study coordinator: Arne Vaaler, PhD MD
- Email: arne.e.vaaler@ntnu.no
- Phone: +47 92090415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
-
À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness
This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.
-
Brenipatide for adults with bipolar disorder (RENEW-Bipolar-1)
This trial will test whether adding brenipatide to standard bipolar medications can delay worsening of symptoms in adults with bipolar I or II.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.